Indolent Lymphoma
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00441 | Gemcitabine | 1 / 2 | Terminated | 1 |
| DB00526 | Oxaliplatin | 1 / 2 | Terminated | 1 |
| DB00073 | Rituximab | 1 / 2 | Recruiting | 1 |
| DB00073 | Rituximab | 1 / 2 | Terminated | 1 |
| DB00188 | Bortezomib | 2 | Completed | 1 |
| DB00242 | Cladribine | 2 | Completed | 1 |
| DB09054 | Idelalisib | 2 | Recruiting | 1 |
| DB09027 | Ledipasvir | 2 | Not Yet Recruiting | 1 |
| DB11697 | Pacritinib | 2 | Completed | 1 |
| DB00073 | Rituximab | 2 | Completed | 1 |
| DB08934 | Sofosbuvir | 2 | Not Yet Recruiting | 1 |